Moving toward a new kind of medicine - (Oct/01/2021 )

Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives. https://pubmed.ncbi.nlm.nih.gov/34591693/

Jon - I've edited out some obvious spam that you had quoted here. The poster had probably edited their response to include links. Bob.

Are you really suggesting psychotherpay as an alternative treatment for the diseases discussed in the paper I cited?  By what mechanism do you propose that psychotherpay might alter the clinical course of genetic conditions like Duchenne muscular dystrophy or spinal muscle atrophy?